Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment.

Pharmacoeconomics · 2023 · PMC9928913 · PMID 36658308

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

The proportion of CUAs using disutilities of AEs in 2019, 2020, and 2021 was 47% (51/107), 50% (65/129), and 61 % (116/190), respectively, showing an increasing trend.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.